Abbott India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
January 14, 2024
Share
Abbott India Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 14,371.4 million compared to INR 13,221.9 million a year ago. Revenue was INR 14,927.5 million compared to INR 13,664.2 million a year ago. Net income was INR 3,109.8 million compared to INR 2,468.3 million a year ago. Basic earnings per share from continuing operations was INR 146.34 compared to INR 116.16 a year ago. Diluted earnings per share from continuing operations was INR 146.34 compared to INR 116.16 a year ago.
For the nine months, sales was INR 44,102.8 million compared to INR 40,056.5 million a year ago. Revenue was INR 45,774 million compared to INR 41,101.6 million a year ago. Net income was INR 9,141.6 million compared to INR 7,179.9 million a year ago. Basic earnings per share from continuing operations was INR 430.19 compared to INR 337.88 a year ago. Diluted earnings per share from continuing operations was INR 430.19 compared to INR 337.88 a year ago.
Abbott India Limited is an India-based company that is engaged in the pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolic, multi-specialty, and vaccines, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), Duvadilan (preterm labor), and others. It offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure, Glucerna, and others.